Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003131279 | SCV003811414 | uncertain significance | Congenital muscular dystrophy due to integrin alpha-7 deficiency | 2022-03-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003131279 | SCV004557449 | uncertain significance | Congenital muscular dystrophy due to integrin alpha-7 deficiency | 2023-04-10 | criteria provided, single submitter | clinical testing | Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ITGA7 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 2432908). This variant has not been reported in the literature in individuals affected with ITGA7-related conditions. This variant is present in population databases (rs747302062, gnomAD 0.003%). This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 315 of the ITGA7 protein (p.Arg315Cys). |